tiopronin has been researched along with Cardiac Hypertrophy in 2 studies
Tiopronin: Sulfhydryl acylated derivative of GLYCINE.
Cardiac Hypertrophy: Enlargement of the HEART due to chamber HYPERTROPHY, an increase in wall thickness without an increase in the number of cells (MYOCYTES, CARDIAC). It is the result of increase in myocyte size, mitochondrial and myofibrillar mass, as well as changes in extracellular matrix.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Myocardial infarction was induced by 20-minute coronary occlusion/reperfusion in spontaneously hypertensive stroke-prone rats (SHR-SPs) and their controls (Wistar-Kyoto rats [WKYs])." | 1.37 | Hypertensive hypertrophied myocardium is vulnerable to infarction and refractory to erythropoietin-induced protection. ( Itoh, T; Kouzu, H; Kuno, A; Miki, T; Miura, T; Sato, T; Shimamoto, K; Takada, A; Tanno, M; Yano, T, 2011) |
| "Antioxidant changes in juvenile visceral steatosis (JVS) mice, a model of heart hypertrophy due to disorder of fatty-acid oxidation, were examined at 4 weeks (developing hypertrophy stage) and 8 weeks of age (established hypertrophy stage)." | 1.31 | Antioxidant changes in the hypertrophied heart due to energy metabolic disorder. ( Hayakawa, T; Hayashi, K; Ito, M; Kamiya, H; Matsui, H; Okumura, K; Saburi, Y, 2001) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Yano, T | 1 |
| Miki, T | 1 |
| Tanno, M | 1 |
| Kuno, A | 1 |
| Itoh, T | 1 |
| Takada, A | 1 |
| Sato, T | 1 |
| Kouzu, H | 1 |
| Shimamoto, K | 1 |
| Miura, T | 1 |
| Kamiya, H | 1 |
| Okumura, K | 1 |
| Ito, M | 1 |
| Matsui, H | 1 |
| Saburi, Y | 1 |
| Hayashi, K | 1 |
| Hayakawa, T | 1 |
2 other studies available for tiopronin and Cardiac Hypertrophy
| Article | Year |
|---|---|
Hypertensive hypertrophied myocardium is vulnerable to infarction and refractory to erythropoietin-induced protection.
Topics: Animals; Calcium; Cardiomegaly; Erythropoietin; Hypertension; Male; Mitochondria, Heart; Mitochondri | 2011 |
Antioxidant changes in the hypertrophied heart due to energy metabolic disorder.
Topics: alpha-Tocopherol; Animals; Antioxidants; Blood Pressure; Cardiomegaly; Carnitine; Energy Metabolism; | 2001 |